Annotation Detail

Information
Associated Genes
MMP12
Associated Variants
MMP12 MUTATION
MMP12 MUTATION
Associated Disease
melanoma
Source Database
DisGeNET
Description
The possibility to exploit tumor homing and activity of autologous MMP12-engineered ECFCs represents a novel way to combat melanoma by a personalized therapy, without rejection risk.The i.v. injection of radiolabelled MMP12-ECFCs can thus provide a new theranostic approach to control melanoma progression and metastasis.
Pubmed
25003596
Section of the abstract supporting the evidence
ALL_TEXT_3/3
Number of the section of the abstract supporting the evidence
3
Number of the sentence supporting the evidence
9
Original source reporting the Gene Disease association
BeFree
DisGENET score for the Gene Disease association
0.000271441872080303
Drugs